From Nasdaq: 2024-05-10 17:54:00

The Zacks Research Daily features new reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Visa Inc. (V) and Pfizer Inc. (PFE). Amazon’s first quarter results were driven by Prime and AWS momentum, while Visa is experiencing profit growth from increased payments. Pfizer expects better non-COVID operational revenue growth in future quarters.

Amazon’s expanding global presence and growing capabilities in various sectors are positives. Visa’s strategic acquisitions and alliances are fostering long-term growth. However, Pfizer’s top line is declining due to lower demand for COVID-19 products. Rising client incentives may affect Visa’s adjusted revenues.

Shares of Pfizer have gained +0.4% over the year-to-date period. Pfizer expects non-COVID operational revenue growth in the future. Amazon’s first quarter results were driven by Prime and AWS momentum, while Visa’s strategic acquisitions are fostering long-term growth. Pfizer’s top line is declining due to lower demand for COVID-19 products.

TC Energy’s growth projects should support its earnings and dividend payouts, though the massive debt remains a concern. Martin Marietta is benefiting from infrastructure demand and operational excellence, despite weather-related challenges. Zimmer Biomet is gaining market share globally, although macroeconomic issues are affecting profitability.



Read more at Nasdaq: Top Stock Reports for Amazon.com, Visa & Pfizer